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Abstract
Thirty-six children (27 boys, nine girls) that fulﬁlled CDC criteria for community-acquired infections were diagnosed with bacteraemia
and/or osteomyelitis caused by Staphylococcus aureus during an 18-month period (2006–2008). Antibiotic susceptibility was determined
by an agar dilution method. SCCmec type, carriage of pvl genes, agr type and spa-typing were determined using speciﬁc PCR protocols.
Clonal relatedness was examined by pulsed ﬁeld gel electrophoresis-SmaI and mutilocus sequence typing techniques. From the 36 iso-
lates, eight (22%) corresponded to methicillin-resistant Staphylococcus aureus (MRSA) -t044/042-CC80/CC5-IVc-pvl+-agrIII/II. The highest
genetic diversity was observed among the 28 community-acquired methicillin-susceptible S. aureus (CA-MSSA) isolates: 22 spa-variants
that also grouped by multilocus sequence typing in CC1, CC5, CC6, CC8, CC30, CC80, CC97 and the singletons ST464, ST1467,
ST1468 and ST1469. The pvl genes were detected in all eight CA-MRSA isolates and in eight CA-MSSA isolates (28%), being signiﬁcantly
more frequent among isolates causing osteoarticular infection (11 of 12, 92%) than in the bacteraemic isolates (six of 24, 25%). Based
on patients’ age, three groups were considered: newborns, infants and children. Bacteraemia was diagnosed in all newborns and infants,
whereas in 42% of the children group osteomyelitis was the unique presentation. In most cases, the portal of entry was either the skin
or unknown. In general, favourable outcome was observed, except in four cases—three of whom had severe complications and one
died. In summary, we analysed the epidemiological and genetic background of community-acquired staphylococcal strains causing bacte-
raemic and/or osteomyelitis infections in children from Tunisia, describing three new sequence types and one novel spa type.
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Introduction
Infections caused by community-acquired Staphylococcus aur-
eus, particularly methicillin-resistant, are increasing world-
wide. An important characteristic of these isolates is their
constant evolution to adapt virulence traits so continuous
surveillance is needed [1]. Most of the community-acquired
methicillin-resistant S. aureus (CA-MRSA) infections usually
present minor severity. However, serious manifestations
with major clinical relevance, most of them linked to the
presence of the pvl genes, including necrotizing fasciitis,
pyomyositis, osteoarticular infections and pneumonia, have
been described. CA-MRSA has replaced its methicillin-
susceptible S. aureus (CA-MSSA) counterpart as the major
cause of skin and soft tissue infections [2–4]. Additionally,
the presence of the pvl genes among isolates causing acute
osteomyelitis in children has been related to high inﬂamma-
tory responses [5].
CA-MRSA usually has a particular epidemiology, the most
successful lineage being USA300 [1]. Different studies have
analysed the epidemiology of invasive infections caused by
CA-MRSA, especially in developed countries, but few of
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them focused on CA-MSSA despite this variant being
possibly be more invasive [6,7]. A replacement in the
CA-MSSA-pvl+ lineages has been described [7].
Tunisia has one of the lowest rates of MRSA prevalence
among Mediterranean countries, where the rate is generally
high [8]. However, in our Children’s Hospital of Tunis
(Tunisia), S. aureus is the major pathogen (52%) causing bac-
teraemia and osteoarticular infections in previously healthy
children (Hariga D, Smaoui H, Bouziri A, Hoˆpital d’Enfants
de Tunis; Trifa M., Bouchoucha S., Smaoui H., Kechrid A.,
Microbiologic proﬁle of acute hematogenous osteoarticular
infections in children submitted for publication). The aim of
this work was to establish the epidemiology of both
CA-MRSA and CA-MSSA isolates causing bacteraemia or
osteomyelitis in children from Tunisia, and to characterize
the genetic background of these isolates.
Material and Methods
Bacterial strains
Thirty-six consecutive S. aureus isolates recovered from chil-
dren with community-acquired invasive infection (September
2006–March 2008) attending the Children’s Hospital of Tunis
(Tunisia) were included (Table 1). This centre is a public,
teaching hospital for paediatric patients, providing tertiary
care for Tunis and surrounding areas. The hospital has 322
beds, admitting patients of all ages. In 2008 the paediatric
population served by our hospital was 576 000, and during
the period of the study the number of patients admitted to
our institution was 30539. Clinical and epidemiological data
were prospectively obtained. Infections were classiﬁed as
community-acquired following the CDC criteria, i.e. detection
TABLE 1. Characteristics of newborns, infants and children, infection site, antibiotic treatment and staphylococcal strains
included in this study
MLST (CC-ST) spa-typing (CC-t) PFGE Strain mec agr pvl Resistance Age Sex
Portal of
entrya Infection Treatment Outcomeb
Newborns
CC80-ST728 CC359/224- t2883 7 9235 – I ) 36 days Male B Cf
CC80-ST728 CC359/224-t189 7 664 – I ) 52 days Male B Cf+Gm
CC80-ST728 CC359/224-t044 1b 19 201 IVc III + Km 58 days Male Skin B Ox+Gm
ST464 CC359/224-t224 21 621 – I ) Km 10 days Male B Ox+Gm
CC5-ST8 CC062-t062 2 1287 IVc II + Te, Tb 4 days Male B Tc+Gm
CC5-ST5 Singleton-t311 17 18 343 – II ) Te, Er 34 days Male Auricular B A/C
Infants
CC80- ST728 CC359/224-t044 1a 10032 IVc III + Te 8 months Male B Vc+Gm Surgery
CC80- ST728 CC359/224-t044 25 17489 – III + 1 year Male B Ox+Gm
CC80- ST728 CC359/224-t044 25 24422 – III + Rf 2 years Male Skin B Ox+Gm
CC1-ST1 Singleton-t127 13 15189 – III ) Er 5 months Male B Ox+Gm
CC1-ST199 t605c 15 7987 – II ) Er 2 years Male B Ox+Gm Dead
CC30-ST30 CC318-t318 3 18609 – III + 4 months Male Respiratory B Ox+Gm
CC6-ST932 Cluster 4-t701 8 11632 – I ) 5 months Male Skin B Ox+Gm
ST1469c Singleton-t903 11 15631 – II + 2 years Male B+O Hip Ox+Gm
ST1468c Singleton-t2313 14 10282 – I ) 2 years Female B+O Tibia Fo+Cf
Children
CC80-ST728 CC359/224-t042 1a 17366 IVc III + 8 years Male O Tibia Tc+Gm
CC80-ST728 CC359/224-t044 1a 4931 IVc III + Er, Km 13 years Female O Tibia-Femur Tc+Py Necrosis
femur
CC80-ST728 CC359/224-t044 1c 13452 IVc III + Km 14 years Male B+O Tc+Gm
CC80-ST728 CC359/224-t044 1d 1109 IVc III + Km 11 years Male O Ankle Tc+Py
CC80-ST728 CC359/224-t044 1e 19913 IVc III + Er, Km 8 years Male O Tc+Gm
CC80-ST728 Singleton t1951- 4 10198 – III + 11 years Female O Femur Ox+Gm
CC1-ST772 CC318-t3634 5 315 – III + 10 years Male O Femur Ox+Gm Sepsis
CC1-ST772 CC318-t113 5 18242 – III + Te 10 years Female O Tibia Ox+Gm
CC1-ST772 CC318-t021 5 23522 – III + 7 years Male O Femur Ox+Gm Chronic O
CC1-ST1 Singleton-t127 10 23617 – III ) 5 years Male Respiratory B Ox+Gm
CC5-ST5 CC062-t5427 16 7141 – II ) 8 years Male B Ox+Gm
CC5-ST5 CC062-t688 12 15459 – II ) Te, Cl 10 years Male Skin B A/C
CC5-ST125 Singleton-t067 24 10015 – III ) 13 years Male B Ox+Gm
CC6-ST932 Cluster 4-t701 23 3410 – I ) Er 3 years Female Skin B Ox+Gm
CC6-ST932 Cluster 4-t701 22 6354 – I ) 11 years Female B Cf+Gm Cardiopathy
CC8-ST8 Singleton-t1705 19 412 – I ) 6 years Female Skin B Ox+Gm
CC8-ST770 Singleton-t068 19 2140 – I ) Te 3 years Female Urinary B Cf+Fo
CC30-ST30 CC318-t021 6 1718 – III ) Er 4 years Male Skin O Hip Ox+Gm
CC30-ST30 CC318-t021 6 2140 – III ) Te, Er 11 years Female Respiratory B Ox+Gm
CC97-ST97 CC359/224-t359 20 1016 – I ) Er 11 years Male B Ox+Gm
ST1467c Cluster 4-t304 18 199 – I ) Er 5 years Male Skin abscess B Ox-Gm
MLST, multilocus sequence typing; PFGE, pulsed ﬁeld electrophoresis; CC, clonal complex; B, bacteraemia; O, osteomyelitis; Ox, oxacillin; Gm, gentamicin; Tc, teicoplanin;
Cf, cefotaxime; Vc, vancomycin; A/C, amoxicillin/clavulanate; Fo, fosfomycin; Py, pristinamycin; Km, kanamycin; Te, tetracycline; Er, erythromycin; Tb, tobramycin; Cl,
chloramphenicol.
aOnly known portals are described.
bOnly non-favourable outcome is reported.
cNewly described.
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of the infection within 48 h of admission and the absence of
contact with hospitals in the last 6 months, except for the
newborns, (http://www.cdc.gov/mrsa/index.html).
Antimicrobial susceptibility testing
Susceptibility to oxacillin, clindamycin, kanamycin, tobramy-
cin, gentamicin, vancomycin, erythromycin, pristinamycin,
quinupristin/dalfopristin, rifampin, tetracycline, ciproﬂoxacin,
chloramphenicol and linezolid was determined by the agar
dilution method following the CLSI guidelines [9]. Addition-
ally, methicillin-resistance was also conﬁrmed using both
30 lg cefoxitin and 1 lg oxacillin discs (Oxoid Ltd, Basing-
stoke, UK) on Mueller–Hinton agar (Difco, Detroit, MI,
USA) supplemented with both 4% NaCl and 6 lg/mL oxacil-
lin [10]. b-Lactamase production was tested by nitroceﬁn
disks (BD Biosciences, Franklin Lakes, NJ, USA) after induc-
tion with penicillin [11]. American Type Culture Collection
(ATCC) MRSA 49775 and MSSA 25923 strains were
included as controls.
SCCmec typing, pvl detection and agr typing
A multiplex PCR scheme was used to determine SCCmec
type, according to a previously described method [12]. Addi-
tional typing of the isolates was performed using two differ-
ent PCR methods to detect SCCmec-IV subtypes IVa, IVb,
IVc, IVd and IVh [13], and SCCmec type V [14]. Presence of
pvl genes was conﬁrmed by speciﬁc PCR [15] using the
MRSA ATCC 49775 strain as positive control. The scheme
described by Shopsin et al. [16] was used to determine the
speciﬁc agr types.
DNA sequencing of the spa gene
The polymorphic X region of the protein A-coding gene
(spa) was ampliﬁed from all isolates, as described previously
[17]. Nucleotide sequences were analysed using the software
RIDOM STAPHTYPE (Ridom GmbH, Wu¨rzburg, Germany) as
described by Harmsen et al. [18]. The BURP (‘Based Upon
Repeat Patterns’) algorithm, as implemented in the RIDOM
STPAHTYPE software, was used to cluster spa types in spa-
Clonal Complex (CC) spa [19].
Clonal relatedness
Pulsed ﬁeld gel electrophoresis (PFGE) was applied to ana-
lyse genetic relatedness of all isolates using a CHEF DR-III
apparatus (Bio-Rad, Birmingham, UK) with the Lambda
Ladder PFGE Marker (New England Biolabs Inc., Beverly,
MA, USA) with SmaI digestion and the HARMONY proto-
col [20]. Macrorestriction fragments were compared and
interpreted both visually and with the PHORETRIX 5.0
software, using the Dice coefﬁcient for the dendrogram
construction and clone deﬁnition. All isolates were analysed
by multilocus sequence typing (MLST) (http://www.mlst.net)
and the results obtained were also analysed using the
EBURST software.
Statistical analysis
Chi-square test was applied, and p values £0.05 were consi-
dered as signiﬁcant.
Results
Epidemiological and clinical characteristics
From September 2006 to March 2008 a total of 36 previously
healthy children (27 boys and nine girls) attended our Hospital
because of invasive infections caused by CA-S. aureus. Taking
into account their ages, three different groups were consid-
ered: newborns (up to 2 months, n = 6), infants (from
2 months to 2 years, n = 9) and children (from 2 years to
14 years, n = 21) (Table 1).
The average age of the six newborns was 32 days (from
4 days to 58 days), and all of them were boys who displayed
an episode of bacteraemia that favourably evolved after anti-
biotic treatment (Table 1). Among the six isolates recovered,
CC80 (two MSSA and one MRSA), CC5 (one MSSA and one
MRSA), and the singleton ST464 were identiﬁed. Different
spa types were detected in the six isolates, suggesting unre-
lated sources.
Seven infants were diagnosed with bacteraemia and
another two had bacteraemia plus osteomyelitis. The average
age of this group was 1 year and 2 months (from 4 months
to 2 years). Favourable outcome was obtained after antibi-
otic treatment except in two cases: a 2-year-old toddler died
(MSSA-t605-ST199-pvl)), and an 8-month-old infant needed
surgery (MRSA-t044-ST728-CC80-IVc-pvl+). In this group,
three ST728 isolates showing a unique t044 spa type but
with differences in pvl or SCCmec carriage, as well as in the
pulsotype or in the resistance pattern, were detected.
In the children group (n = 21), the average age was
8.6 years. Eleven suffered a bacteraemic infection, nine had
osteomyelitis in their lower extremities and one presented
with both bacteraemia and osteomyelitis. The skin was the
most common portal of entry. The MRSA-t044/t042-ST728-
CC80-IVc-pvl+ isolates were identiﬁed in ﬁve cases; whereas
in the MSSA isolates, pvl genes were present in four of 16
isolates (Table 1). Clinical outcome was observed in all but
four cases (in which three MSSA (two of them pvl+) and one
MRSA were involved).
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Statistically signiﬁcant proportions of boys (p £0.001)
were recorded in the newborns (all six were boys),
infants (eight of nine were boys) and children (13 of 21 were
boys).
Antimicrobial susceptibility testing
From the 36 isolates, eight (22%) were resistant to oxacillin
(both by the agar dilution method in Mueller–Hinton agar
supplemented with 4% NaCl plus 6 lg/mL oxacillin and by
cefoxitin/oxacillin discs) and for MSSA isolates MICs varied
from 0.125 to 1 lg/mL. All CA-MRSA isolates showed a
positive reaction for the b-lactamase test, whereas negative
results were obtained in the MSSA isolates. MIC results from
the agar dilution method showed that all isolates were sus-
ceptible to vancomycin (£1 lg/mL), ciproﬂoxacin, gentamicin,
linezolid (£2 lg/mL) and quinupristin/dalfopristin.
Detection of mecA gene, SCCmec typing, agr type and pvl
carriage
After susceptibility results, all MRSA isolates (n = 8) har-
boured both mecA and pvl genes and their SCCmec corre-
sponded to type IVc. The great majority of the MRSA
isolates (seven of eight) had the agr type III but differences in
their pulsotype or in the antibiotic-resistance patterns were
observed; two spa variants were detected, the most frequent
being t044. One strain presented the agr type II (Table 1).
Among the 28 MSSA isolates, agr type III was also the
most prevalent (n = 12, 43%), followed by type I (n = 11,
38%) and ﬁnally agr type II (n = 5, 17%). On the other hand,
pvl genes were detected in eight isolates (28%). Taking into
account all isolates, detection of pvl genes was signiﬁcantly
more frequent among isolates causing osteoarticular infection
(ten of 12, 83%) than in those of bacteraemic origin (six of
24, 25%) (p £ 0.001).
spa-typing and BURP analysis
All isolates were successfully spa-typed, although in one iso-
late fewer than ﬁve repeats were detected so this isolate
was excluded from the analysis. A higher diversity in the spa
types (21 types among 28 isolates) was detected for the
MSSA isolates than for the MRSA isolates (three types
among eight isolates). All isolates were grouped into four
clusters: Cluster 1, spa-CC359/224 (13 isolates: seven MRSA
and six MSSA, 36%) with six spa types the predominant one
being t044; Cluster 2, spa-CC318 (six MSSA isolates, 17%)
with four spa types; Cluster 3, spa-CC062 (three spa types,
two MSSA and one MRSA isolates, 8%) and Cluster 4 with
no founder identiﬁed (two spa types, four MSSA isolates,
11%) and eight singletons. The t5427 spa type detected in
the MSSA-CC5 isolate has not been previously reported
(Fig. 1).
Clonal relatedness
Two PFGE patterns were detected among the eight MRSA
isolates, one of them presenting ﬁve highly related subtypes
(1a, 1b, 1c, 1d and 1e). The 28 MSSA isolates were classiﬁed
into 23 different pulsotypes and only three of them grouped
as more than one isolate, suggesting a high genetic diversity.
ST728-CC80 grouped 12 isolates with four pulsotypes and
six spa variants. Other less represented lineages were CC1
(six isolates), CC5 (ﬁve isolates), CC30 (three isolates) and
CC6 (three isolates) including different PFGE and spa types.
Three MSSA isolates presented an allelic combination not
previously reported and were registered in the MLST
Cluster 1
Cluster 2
Cluster 3
Cluster 40.01
t1705 singleton
t068 singleton
t2313 singleton
t1951 singleton
t903 singleton
t311 singleton
t067 singleton
t688 CC062
t062 CC062 MRSA
t5427 CC062
t127 singleton 2 isolates
t224 CC359/224
t359 CC359/224
t189 CC359/224
t2883 CC359/224
t042 CC359/224 MRSA
t044 CC359/224 8 isolates (6 MRSA)
t3634 CC318
t1130 CC318
t318 CC318
t021 CC318 3 isolates
t701 no founder 3 isolates
t304 no founder
FIG. 1. Distribution of spa types
detected in isolated invasive community-
acquired methicillin-susceptible (CA-MSSA;
n = 28) and community-acquired methi-
cillin-resistant (CA-MRSA; n = 8) Staphy-
lococcus aureus causing invasive infection
in children from Tunisia (‘Based Upon
Repeat Patterns’ (BURP) analysis). One
isolate presented fewer than ﬁve
repeats and was deleted from the BURP
analysis.
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database as ST1467, ST1468 and ST1469 (http://saure-
us.mlst.net/).
Discussion
Considerable epidemiological differences in the isolates caus-
ing staphylococcal infections have been demonstrated in
numerous studies, mostly focused on those from developed
countries. The source of the infection is one of the most
important factors of divergence: i.e. of hospital or commu-
nity origin. CA-MRSA is increasing worldwide, particularly
associated with more virulence and effectiveness in host-to-
host transmission [1] and recent replacements in the genetic
lineages have been reported [7]. Prevalence of severe inva-
sive infections caused by CA-S. aureus in children is also
increasing in our Paediatrics Hospital in Tunis (Hariga D,
Smaoui H, Bouziri A, Kechrid A, Hoˆpital d’Enfants de Tunis,
submitted for publication). Nasal carriage of S. aureus in
children of our region was 47.8%, only 1% corresponding to
MRSA (Zouari A, Smaoui H, Hajji N, Chahed M, Kechrid A,
Hoˆpital d’Enfants de Tunis, submitted for publication). The
objective of this work was to analyse the epidemiological
and molecular features of these invasive isolates.
During 19 months, we attended 36 children with S. aureus
infections that fulﬁlled the CDC criteria for community-
acquired infection (1.8 cases per month). Based on their
different ages, we considered three groups: newborns,
infants and children. The source of infective S. aureus strains
in the newborns could be related to their family contacts,
whereas in the case of infants and children a great variety of
sources must be considered, including environment and trau-
matic injuries. Bacteraemia was diagnosed in all newborns
and infants, whereas in 42% of the children group osteomy-
elitis was the unique clinical presentation.
Doit et al. have recently published the epidemiological
features of paediatric community-acquired bloodstream infec-
tions in France, demonstrating that S. aureus is the most
frequent aetiological agent in children older than 5 years; the
isolates without pvl being the most commonly detected [21].
In another study, S. aureus remained the prevalent organism
causing acute osteomyelitis in children, with an increasing
occurrence of MRSA isolates [22]. In addition, association of
S. aureus infections with musculoskeletal complications has
been described [23–25].
Signiﬁcant association between CA-S. aureus and boys was
observed in this study, particularly in newborns and infants.
This speciﬁc gender association for staphylococcal infections
has been previously described by Sdougkos et al. [26].
In most cases, the portal of entry was unknown or was
attributed to skin injuries. In three cases, a respiratory
focus was recorded. Ear and urinary tract were described as
other sources. It is important to consider differences in age
because toddlers have more chances to suffer traumatic
injuries and to have contact with contaminated surfaces.
We found a high prevalence of pvl genes among both the
MRSA (all eight isolates) and the MSSA (eight of 28; 28.5%)
isolates. This virulence factor has been described in Tunisian
strains associated with agr type II; although type III was the
most prevalent among the Tunisian MRSA strains [27]. In
our collection, pvl+ strains were mostly linked to agr type III
(13 out of 15 strains) whereas two strains had the agr type
II. The agr type IV, which is common among exfoliatin-pro-
ducing strains [28], was not identiﬁed in our population.
In general, a favourable outcome was observed in patients
infected with MSSA isolates. Nevertheless, in four cases, two
of them pvl+, severe complications were observed, and one
2-year-old infant died as a consequence of his MSSA infec-
tion. All but one were treated with antibiotic combinations,
the most frequent being oxacillin plus gentamicin. For MRSA
isolates, a glycopeptide plus gentamicin or pristinamycin were
used. In the case of MRSA isolates, it has been shown that
oxacillin increases the Panton-Valentine leukocidin protein
expression [29]; as a result of this, two protein synthesis
inhibitors, mainly erythromycin or clindamycin, are recom-
mended [30,31]. Our patients were enrolled before the
publication of this communication, however, oxacillin with
gentamicin was prescribed in nine patients, with good results
seven of them.
The absence of an antibiotic multi-resistance phenotype,
presence of SCCmec type IVc in the MRSA isolates, and the
great variety of genetic backgrounds supported the commu-
nity origin of our isolates. The USA300 clone has emerged
worldwide as a virulent hyper-epidemic strain. Within this
clone, a particularly virulent CC8-sublineage has been
described [1]. These virulent strains were absent from our
collection but our MRSA strains were linked to t044/t042-
ST728-CC80, which has been mainly described in central
Europe [32,33]. Similar to our results, Ben Nejma et al. [27]
reported the widespread occurrence of MRSA-t044-ST80-IV-
pvl+ in community isolates obtained from adults in Tunisia,
although higher diversity of lineages was obtained among our
isolates. Moreover, ST772 is a single locus variant of ST80,
which could indicate a recent evolution although both vari-
ants present the same spa type t044.
In summary, we analysed the epidemiological and genetic
background of community-acquired staphylococcal strains
causing bacteraemia and osteomyelitis in children. Within
this population, we found a low representation of MRSA
strains (22%) but with high prevalence of pvl factor linked
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to agr group III, and a high genetic diversity in the MSSA
isolates when compared with MRSA isolates.
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